.png)
Clinical Collaboration
Mayo Clinic Partnership
Sersense is collaborating with Mayo Clinic on biomarker discovery and the translation of research into accessible diagnostic technologies. This strategic collaboration ensures that our solutions are validated through rigorous clinical research and real-world medical data.
Non-Dilutive Funding
Sersense has secured competitive Small Business Innovation Research (SBIR) funding to support development of biomarker-based diagnostic technologies. This non-dilutive capital enables rigorous research and development while maintaining mission-driven equity for our long-term clinical objectives.
SBIR Funding Impact
Accelerated development of diagnostic platforms.
Intellectual Property
Sersense maintains a robust patent portfolio protecting its core diagnostic algorithms and platform architecture.
3+ Patents Filed
$3.1 M+
Non-Dilutive Funding Secured
3+
Patents Filed
Mayo Clinic
Clinical Collaboration